Annual Scientific Meeting

Challenges in Hepatitis C Management: DAA Failures, Special Populations, and Controversies

Tuesday, October 9
11:50 AM - 12:10 PM
Location: Terrace Ballroom 4 (level 400)

Category: Liver

Learning Objectives:

Mitchell L. Shiffman

Director
Liver Institute of Virginia, Bon Secours Health System
Richmond, VA, US

Mitchell L. Shiffman, MD, FACG, is the Director of the Liver Institute of Virginia, with offices in Richmond and Newport News, VA. He received his MD degree from the State University of New York, Upstate Medical Center in Syracuse, NY. He completed internship and residency training in Internal Medicine and fellowship training in Gastroenterology and Hepatology at the Virginia Commonwealth University Medical Center. He served as the Chief of the Hepatology Section and Medical Director of the Liver Transplant Program at the Virginia Commonwealth University Medical Center in Richmond, VA, from 1990-2009. Dr. Shiffman joined the Bon Secours Health System and started the Liver institute of Virginia in 2010. Dr. Shiffman is considered an International Key Opinion Leader in Hepatology, is a consultant to many pharmaceutical companies working in this space, and a site principle investigator for numerous clinical trials involving various liver diseases. Dr. Shiffman has published over 300 original articles, reviews and/or book chapters, and has edited 3 textbooks on liver disease. He served as a member of the ACG Board of Trustees from 2003-2009, and was a member of the ACG Institute Board between 2005-2013. He is currently an Associate Editor of the ACG Education Universe. Dr. Shiffman has served on numerous ACG committees and NIH grant review committees, and is a regular reviewer for several medical journals.

Presentation(s):

Send Email for Mitchell Shiffman


Assets

Challenges in Hepatitis C Management: DAA Failures, Special Populations, and Controversies



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Challenges in Hepatitis C Management: DAA Failures, Special Populations, and Controversies